Neuro-Oncology Reviews

Volume 24 Number 16
31 August 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 16, 31 August

Edwards L, Habib A, Zinn PO.
Editorial: Rising stars in neuro-oncology and neurosurgical oncology 2021.
Front Oncol. 2022 Aug 16;12:940063→. doi: 10.3389/fonc.2022.940063→. PMID: 36052223→. Editorial. ˍ

Hatoum R, Chen JS, Lavergne P, Shlobin NA, Wang A, Elkaim LM, Dodin P, Couturier CP, Ibrahim GM, Fallah A, Venne D, Perreault S, Wang AC, Jabado N, Dudley RWR, Weil AG.
Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Aug 16;5(8):e2226551→. doi: 10.1001/jamanetworkopen.2022.26551→. PMID: 35972743→. Review, Meta-analysis. ˍ

Liang S, Fan X, Chen F, Liu Y, Qiu B, Zhang K, Qi S, Zhang G, Liu J, Zhang J, Wang J, Wang X, Song Z, Luan G, Yang X, Jiang R, Zhang H, Wang L, You Y, Shu K, Lu X, Gao G, Zhang B, Zhou J, Jin H, Han K, Li Y, Wei J, Yang K, You G, Ji H, Jiang Y, Wang Y, Lin Z, Li Y, Liu X, Hu J, Zhu J, Li W, Wang Y, Kang D, Feng H, Liu T, Chen X, Pan Y, Liu Z, Li G, Li Y, Ge M, Fu X, Wang Y, Zhou D, Li S, Jiang T, Hou L, Hong Z.
Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery.
Ther Adv Neurol Disord. 2022 Aug 16;15:17562864221114357→. doi: 10.1177/17562864221114357→. PMID: 35992894→. Guidelines. ˍ

Lu M, Zhou Y, Sun L, Shafi S, Ahmad N, Sun M, Dong J.
The molecular mechanisms of ferroptosis and its role in glioma progression and treatment.
Front Oncol. 2022 Aug 16;12:917537→. doi: 10.3389/fonc.2022.917537→. PMID: 36091118→. Review. ˍ

Wang G, Wang W.
Advanced Cell Therapies for Glioblastoma.
Front Immunol. 2022 Aug 16;13:904133→. doi: 10.3389/fimmu.2022.904133→. PMID: 36052072→. Review. ˍ

Shams S, Patel CB.
Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).
J Mol Cell Biol. 2022 Aug 16:mjac047→. doi: 10.1093/jmcb/mjac047→. PMID: 35973687→. Review. ˍ

Zhang HM, Huo XB, Wang HL, Wang C.
Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiating Recurrence From Radiation Injury in Postoperative Glioma: A Meta-analysis.
J Comput Assist Tomogr. 2022 Aug 16→. doi: 10.1097/RCT.0000000000001356→. PMID: 35969866→. Meta-analysis˰ ˍ

Zhang G, Li J, Hui X.
Use of 18F-FDG-PET/CT in differential diagnosis of primary central nervous system lymphoma and high-grade gliomas: A meta-analysis.
Front Neurol. 2022 Aug 17;13:935459→. doi: 10.3389/fneur.2022.935459→. PMID: 36061992→. Meta-analysis. ˍ

Zhuo S, He G, Chen T, Li X, Liang Y, Wu W, Weng L, Feng J, Gao Z, Yang K.
Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges.
Front Mol Biosci. 2022 Aug 17;9:974156→. doi: 10.3389/fmolb.2022.974156→. PMID: 36060242→. Review. ˍ

*

Onwudiwe K, Burchett AA, Datta M.
Mechanical and metabolic interplay in the brain metastatic microenvironment.
Front Oncol. 2022 Aug 18;12:932285→. doi: 10.3389/fonc.2022.932285→. PMID: 36059679→. Review. ˍ

Crowell C, Mata-Mbemba D, Bennett J, Matheson K, Mackley M, Perreault S, Erker C.
Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors.
Neurooncol Adv. 2022 Aug 19;4(1):vdac133→. doi: 10.1093/noajnl/vdac133→. PMID: 36105387→. Review. ˍ

Cao TQ, Wainwright DA, Lee-Chang C, Miska J, Sonabend AM, Heimberger AB, Lukas RV.
Next Steps for Immunotherapy in Glioblastoma.
Cancers (Basel). 2022 Aug 20;14(16):4023→. doi: 10.3390/cancers14164023→. PMID: 36011015→. Review. ˍ

Rizzo A, Dall'Armellina S, Pizzuto DA, Perotti G, Zagaria L, Lanni V, Treglia G, Racca M, Annunziata S.
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
Cancers (Basel). 2022 Aug 21;14(16):4039→. doi: 10.3390/cancers14164039→. PMID: 36011032→. Review. ˍ

Hanganu B, Lazar DE, Manoilescu IS, Mocanu V, Butcovan D, Buhas CL, Szalontay AS, Ioan BG.
Controversial Link between Cannabis and Anticancer Treatments-Where Are We and Where Are We Going? A Systematic Review of the Literature.
Cancers (Basel). 2022 Aug 22;14(16):4057→. doi: 10.3390/cancers14164057→. PMID: 36011049→. Review. ˍ

Shi J, Yang N, Han M, Qiu C.
Emerging roles of ferroptosis in glioma.
Front Oncol. 2022 Aug 22;12:993316→. doi: 10.3389/fonc.2022.993316→. PMID: 36072803→. Review. ˍ

Mallick S, V R A, Giridhar P, Upadhyay R, Kim BK, Sharma A, Elghazawy H, Elumalai T, Solipuram V, Hsieh CE, Hentz C, Solanki AA, Li J, Chan DP, Ness E, Venkatesulu BP, Grosshans DR.
A Systematic Review and Meta-analysis of the Impact of Radiation-Related Lymphopenia on Outcomes in High-Grade Gliomas.
South Asian J Cancer. 2022 Aug 23;11(4):361-369→. doi: 10.1055/s-0042-1753504→. PMID: 36756098→. Review, Meta-analysis. ˍ

Dominari A, Antoniades E, Capiccelo A, Hatzipantelis E, Foroglou N.
Remote Supratentorial Recurrent Medulloblastoma: Case Study and Literature Review.
Asian J Neurosurg. 2022 Aug 24;17(2):286-301→. doi: 10.1055/s-0042-1750389→. PMID: 36120640→. Case report, Review. ˍ

Liu G, Qiu Y, Zhang P, Chen Z, Chen S, Huang W, Wang B, Yu X, Guo D.
Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies.
Pharmaceutics. 2022 Aug 24;14(9):1762→. doi: 10.3390/pharmaceutics14091762→. PMID: 36145510→. Review. ˍ

Prieto R, Hofecker V, Corbacho C.
Coexisting lipomatous meningioma and glioblastoma in Cowden syndrome: A unique tumor association.
Neuropathology. 2022 Aug 24→. doi: 10.1111/neup.12858→. PMID: 36003032→. Case report, Review˰ ˍ

Tian W, Zhang W, Wang Y, Jin R, Wang Y, Guo H, Tang Y, Yao X.
Recent advances of IDH1 mutant inhibitor in cancer therapy.
Front Pharmacol. 2022 Aug 24;13:982424→. doi: 10.3389/fphar.2022.982424→. PMID: 36091829→. Review. ˍ

Akindona FA, Frederico SC, Hancock JC, Gilbert MR.
Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma.
Front Oncol. 2022 Aug 25;12:947634→. doi: 10.3389/fonc.2022.947634→. PMID: 36091174→. Review. ˍ

Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN.
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.
JAMA Oncol. 2022 Aug 25→. doi: 10.1001/jamaoncol.2022.2844→. PMID: 36006639→. Review˰ ˍ

Di Ruscio V, Del Baldo G, Fabozzi F, Vinci M, Cacchione A, de Billy E, Megaro G, Carai A, Mastronuzzi A.
Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle.
Diagnostics (Basel). 2022 Aug 25;12(9):2064→. doi: 10.3390/diagnostics12092064→. PMID: 36140466→. Review. ˍ

Shaikh S, Othman H, Marriyam I, Nagaraju S, Kovacevic G, Dardis R.
Intratumoral and Peritumoral Brain Abscess Concomitant with Glioblastoma: Report of Two Cases with Review of Literature.
Asian J Neurosurg. 2022 Aug 25;17(2):310-316→. doi: 10.1055/s-0042-1750384→. PMID: 36120638→. Case report, Review. ˍ

Martín-Rubio P, Espiau-Romera P, Royo-García A, Caja L, Sancho P.
Metabolic determinants of stemness in medulloblastoma.
World J Stem Cells. 2022 Aug 26;14(8):587-598→. doi: 10.4252/wjsc.v14.i8.587→. PMID: 36157911→. Review. ˍ

Awuah WA, Huang H, Kalmanovich J, Mehta A, Kundu M, Toufik AR, Tanna R, Hasan MM, Alexiou A, Sikora V.
Tumour microenvironment: Modulating effects, challenges, and future perspectives of oncolytic virotherapy in Astrocytoma treatment.
Ann Med Surg (Lond). 2022 Aug 28;82:104508→. doi: 10.1016/j.amsu.2022.104508→. PMID: 36186495→. Commentary. ˍ

Bernhardt D, König L, Grosu A, Wiestler B, Rieken S, Wick W, Gempt J, Krieg SM, Schmidt-Graf F, Sahm F, Meyer B, Krause BJ, Petersen C, Fietkau R, Thomas M, Giordano F, Wittig-Sauerwein A, Debus J, Tabatabai G, Hau P, Steinbach J, Combs SE; Expert Panel of the German Society of Radiation Oncology (DEGRO).
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.
Strahlenther Onkol. 2022 Aug 29→. doi: 10.1007/s00066-022-01994-3→. PMID: 36038669→. Guidelines. ˍ

Bernhardt D, König L, Grosu AL, Rieken S, Krieg SM, Wick W, Wiestler B, Schmidt-Graf F, Sahm F, Gempt J, Meyer B, Krause BJ, Petersen C, Fietkau R, Thomas M, Giordano F, Wittig-Sauerwein A, Debus J, Tabatabai G, Hau P, Steinbach J, Combs SE; Expert Panel of the German Society of Radiation Oncology (DEGRO).
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.
Strahlenther Onkol. 2022 Aug 29→. doi: 10.1007/s00066-022-01973-8→. PMID: 36038670→. Guidelines. ˍ

*

Ohno M, Kitanaka C, Miyakita Y, Tanaka S, Sonoda Y, Mishima K, Ishikawa E, Takahashi M, Yanagisawa S, Ohashi K, Nagane M, Narita Y.
Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies.
Cancers (Basel). 2022 Aug 30;14(17):4222→. doi: 10.3390/cancers14174222→. PMID: 36077758→. Interventional study, Review. ˍ

Pace A, Tanzilli A, Benincasa D.
Prognostication in brain tumors.
Handb Clin Neurol. 2022 Aug 30;190:149-161→. doi: 10.1016/B978-0-323-85029-2.00001-4→. PMID: 36055712→. Review˰ ˍ

Sioutas G, Nikova A, Birbilis T.
Risk factors for pediatric glioma.
Folia Med (Plovdiv). 2022 Aug 31;64(4):566-571→. doi: 10.3897/folmed..e64431→. PMID: 36045476→. Review. ˍ

Talloa D, Triarico S, Agresti P, Mastrangelo S, Attinà G, Romano A, Maurizi P, Ruggiero A.
BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors.
Cancers (Basel). 2022 Aug 31;14(17):4264→. doi: 10.3390/cancers14174264→. PMID: 36077798→. Review. ˍ